Filing Details
- Accession Number:
- 0001562180-19-002477
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-02 16:14:27
- Reporting Period:
- 2019-05-01
- Accepted Time:
- 2019-05-02 16:14:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603594 | James Hippel | 614 Mckinley Place N.e. Minneapolis MN 55413 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-01 | 35,000 | $86.25 | 39,382 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-01 | 35,000 | $203.08 | 4,382 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Acquisiton | 2019-05-01 | 10,000 | $0.00 | 10,000 | $86.25 |
| Common Stock | Stock Options (Right to buy) | Acquisiton | 2019-05-01 | 25,000 | $0.00 | 25,000 | $86.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-06-30 | 2021-04-01 | No | 4 | M | Direct |
| 0 | 2018-04-01 | 2021-04-01 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | $0.00 | 3,383 | 3,383 | Direct | ||
| Common Stock | Restricted Stock Units | $0.00 | 4,438 | 4,438 | Direct | ||
| Common Stock | Restricted Stock Units | $0.00 | 4,925 | 4,925 | Direct | ||
| Common Stock | Stock Option (Right to Buy) | $106.59 | 2023-08-18 | 30,400 | 30,400 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $94.35 | 2021-08-12 | 35,000 | 35,000 | Direct | |
| Common Stock | Stock Options (Right to buy) | $177.32 | 2025-08-08 | 24,089 | 24,089 | Direct | |
| Common Stock | Stock Options (Right to buy) | $177.32 | 2025-08-08 | 18,066 | 18,066 | Direct | |
| Common Stock | Stock Options (Right to buy) | $125.05 | 2024-08-09 | 24,460 | 24,460 | Direct | |
| Common Stock | Stock Options (Right to buy) | $125.05 | 2024-08-09 | 32,613 | 32,613 | Direct | |
| Common Stock | Stock Options (Right to buy) | $108.49 | 2022-08-07 | 25,000 | 25,000 | Direct | |
| Common Stock | Stock Options (Right to buy) | $106.59 | 2023-08-18 | 40,533 | 40,533 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 3,383 | 3,383 | Direct | |
| 4,438 | 4,438 | Direct | |
| 4,925 | 4,925 | Direct | |
| 2023-08-18 | 30,400 | 30,400 | Direct |
| 2021-08-12 | 35,000 | 35,000 | Direct |
| 2025-08-08 | 24,089 | 24,089 | Direct |
| 2025-08-08 | 18,066 | 18,066 | Direct |
| 2024-08-09 | 24,460 | 24,460 | Direct |
| 2024-08-09 | 32,613 | 32,613 | Direct |
| 2022-08-07 | 25,000 | 25,000 | Direct |
| 2023-08-18 | 40,533 | 40,533 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.28 to $205.38, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)
- Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- 8,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
- Vests 6,023 shares on 8/8/2019 and 6,022 shares each on 8/8/2020, 8/8/2021 and 8/8/20202
- Vests 8,153 shares each on 8/19/2018, 8/9/2019, 8/9/2020 and 8,154 on 8/9/2021
- 6,250 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- Vests 10,134 shares on 8/18/17, and 10,133 shares on each of 8/18/18, 8/18/19 and 8/18/20.
Billionaire Hedge Funds
